Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05102474 · ClinicalTrials.gov registry record
Dermatologic Research Evaluation and Monitoring of Sleep in Moderate-to-Severe Psoriasis
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 24
- Enrollment target
NCT05102474 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 24 participants.
The verdict
NCT05102474 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
Getting enough sleep is important for maximizing health and well-being. When it comes to health, sleep is as vital as regular exercise and eating a balanced diet. Not getting enough sleep can lead to health problems like heart attacks, diabetes, and even cancer. Since individuals with psoriasis have these same health problems, getting better sleep may help to keep them happier and healthier. This study will look at how individuals with psoriasis sleep and if their sleep is different than indivuduals without psoriasis.
Interventions
- OTHER Polysomnography (PSG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-02-15 |
| Est. Completion | 2024-07-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05102474
The ClinicalTrials.gov registry entry for NCT05102474 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Polysomnography (PSG) is the first listed.
NCT05102474 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05102474 about?
NCT05102474 is a clinical study titled "Dermatologic Research Evaluation and Monitoring of Sleep in Moderate-to-Severe Psoriasis". Getting enough sleep is important for maximizing health and well-being. When it comes to health, sleep is as vital as regular exercise and eating a balanced diet. Not getting enough sleep can lead to health problems like heart attacks, diabetes, and even cancer. Since individuals with psoriasis have...
What is the current status of trial NCT05102474?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2022-02-15. Estimated completion is 2024-07-03.
What interventions are being tested in trial NCT05102474?
The interventions under investigation include: Polysomnography (PSG) (OTHER).
Who is sponsoring clinical trial NCT05102474?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.